Karo Pharma AB Stock
Price
Target price
-
-
-
-
-
?51.32
WKN: A14YW4 / Symbol: KARO / Name: Karo Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Karo Pharma AB Stock
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Karo Pharma AB.
With a target price of 51 € there is potential for a 837.5% increase which would mean more than doubling the current price of 5.44 € for Karo Pharma AB.
Pros and Cons of Karo Pharma AB in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Karo Pharma AB vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Karo Pharma AB | - | - | - | - | - | - | - |
| Active Biotech AB | -8.000% | 2.174% | 34.286% | -41.250% | 6.818% | -91.547% | -96.643% |
| Medivir AB | -18.010% | 4.364% | 333.071% | -28.803% | 223.529% | -85.054% | -86.967% |
| Immunic Inc. | 2.650% | 22.900% | 63.718% | -20.578% | 110.930% | -51.079% | -93.129% |
Comments
Karooooo (NASDAQ:KARO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo (NASDAQ:KARO) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "strong-buy" rating.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "outperform" rating re-affirmed by analysts at Raymond James Financial, Inc.. They now have a $60.00 price target on the stock, up previously from $58.00.
Show more
Ratings data for KARO provided by MarketBeat
